申请人:CHRYSALIS INC
公开号:WO2017143011A1
公开(公告)日:2017-08-24
This disclosure relates to compounds that inhibit histone demethylase activity. In particular, the disclosure relates to compounds that inhibit histone lysine demethylase KDM5B, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions disclosed herein.
这份披露涉及抑制组蛋白去甲基化酶活性的化合物。具体而言,该披露涉及抑制组蛋白赖氨酸去甲基化酶KDM5B的化合物,以及使用这些化合物和药物组合物的方法,例如使用本文披露的化合物和药物组合物治疗癌症的方法。